Lab-grown brain models could provide a new way to test potential treatments for neurodegenerative conditions, including Alzheimer's and Parkinson's disease.
Research presented at the inaugural International Conference on Organoid Intelligence in Washington DC, explained how scientists are growing tiny clusters of human brain cells, known as organoids, and connecting them to electrodes that can send and record electrical signals.
Researchers hope to use these systems to assess how organoids made from people with neurodegenerative conditions respond to potential drugs. The approach could also help reduce reliance on animal testing and eventually support more personalised treatments by testing drugs on brain cells derived from individual patients.
However, researchers say that further work is needed to standardise the technology before it can be widely used in drug development.
Read more in Being Patient.
